A randomized noninferiority trial of condensed protocols for genetic risk disclosure of Alzheimer's disease

Alzheimer's and Dementia

Volumn 11, Issue 10, 2015, Pages 1222-1230

  Green, Robert C ^a,b   Christensen, Kurt D ^a   Cupples, L Adrienne ^c   Relkin, Norman R ^d   Whitehouse, Peter J ^e   Royal, Charmaine D M ^f   Obisesan, Thomas O ^g   Cook Deegan, Robert ^f   Linnenbringer, Erin ^h   Butson, Melissa Barber ^e   Fasaye, Grace Ann ⁱ   Levinson, Elana ^j   Roberts, J Scott ^k   Bhatt, D ^a   Biesecker, B ^l   Blacker, D ^a   Chen, C ^c   Cox, E ^d   Davis, J G ^d   Farrer, L ^m   Griffith, P ⁿ   Harkins, K ^o   Hiraki, S ^p   Johnson, M ^q   Johnson, S ^q   Juengst, E ^r   Karlawish, J ^o   Le, L ^k   McCarty Wood, E ^o   Obisesan, T ^q   Post, S ^s   Quaid, K ^t   Ravdin, L ^d   Roter, D ^u   Stern, R ^m   Sadovnick, A ^v   Sami, S ^w   Sankar, P ^o   Topol, E ^x   Uhlmann, W ^y   Waterston, L ^z   Wright, L ^aa   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b LABORATORY FOR MOLECULAR MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f DUKE UNIVERSITY   (United States)

^g HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ WALTER REED ARMY MEDICAL CENTER   (United States)

^j Och Spine at New York Presbyterian Hospitals   (United States)

^k UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^l National Human Genomics Research Institute   (United States)

^m BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ MOREHOUSE SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

^p ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^q HOWARD UNIVERSITY   (United States)

^r UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^s STONY BROOK UNIVERSITY   (United States)

^t INDIANA UNIVERSITY   (United States)

^u JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^v UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^w CASE WESTERN RESERVE UNIVERSITY   (United States)

^x SCRIPPS RESEARCH INSTITUTE   (United States)

^y UNIVERSITY OF MICHIGAN   (United States)

^z Maine Medical Center Research Institute   (United States)

^aa MEDICAL COLLEGE OF GEORGIA   (United States)

more..

Author keywords

Alzheimer; APOE; Genetics; Genomics; Personalized medicine; Risk assessment

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ALZHEIMER DISEASE; ANXIETY; APOE GENE; ARTICLE; CLINICAL PROTOCOL; DEPRESSION; DISEASE SEVERITY; EUROPEAN AMERICAN; FEMALE; FIRST DEGREE RELATIVE; GENE; GENETIC COUNSELING; GENETIC RISK; GENOTYPE; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); CAUCASIAN; CLINICAL TRIAL; CONTROLLED STUDY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

APOLIPOPROTEIN E;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANXIETY; APOLIPOPROTEINS E; DISCLOSURE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; YOUNG ADULT;

EID: 84945438957     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.10.014     Document Type: Article

References (29)

1. R.C. Green, J.S. Roberts, L.A. Cupples, N.R. Relkin, P.J. Whitehouse, T. Brown, and et al. Disclosure of APOE genotype for risk of Alzheimer's disease N Engl J Med 361 2009 245 254
2. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea Guidelines for the molecular genetics predictive test in Huntington's disease J Med Genet 31 1994 555 559
3. J.S. Goldman, S.E. Hahn, J.W. Catania, S. LaRusse-Eckert, M.B. Butson, M. Rumbaugh, and et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors Genet Med 13 2011 597 605
4. E.L. Teng, and H.C. Chui The Modified Mini-Mental State (3MS) Examination. J Clin Psychiatry 48 1987 314 318
5. K.D. Christensen, J.S. Roberts, C.D.M. Royal, G.-A. Fasaye, T. Obisesan, L.A. Cupples, and et al. Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL Study experience Genet Med 10 2008 207 214
6. S. Crean, A. Ward, C.J. Mercaldi, J.M. Collins, M.N. Cook, N.L. Baker, and et al. Apolipoprotein E epsilon4 prevalence in Alzheimer's disease patients varies across global populations: a systematic literature review and meta-analysis Dement Geriatr Cogn Disord 31 2011 20 30
7. M.X. Tang, Y. Stern, K. Marder, K. Bell, B. Gurland, R. Lantigua, and et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics JAMA 279 1998 751 755
8. A.T. Beck, N. Epstein, G. Brown, and R.A. Steer An inventory for measuring clinical anxiety: psychometric properties J Consult Clin Psychol 56 1988 893 897
9. L.S. Radloff The CES-D scale: A self-report depression scale for research in the general population Appl Psychol Meas 1 1977 385 401
10. D.A. Santor, D.C. Zuroff, J.O. Ramsay, P. Cervantes, and J. Palacios Examining scale discriminability in the BDI and CES-D as a function of depressive sererity Psychol Assess 7 1995 131 139
11. M. Horowitz, N. Wilner, and W. Alvarez Impact of Event Scale: a measure of subjective stress Psychosom Med 41 1979 209 218
12. K. Payne, S. Nicholls, M. McAllister, R. MacLeod, D. Donnai, and L.M. Davies Outcome measurement in clinical genetics services: A systematic review of validated measures Value Health 11 2008 497 508
13. J.S. Roberts, L.A. Cupples, N.R. Relkin, P.J. Whitehouse, and R.C. Green Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) Study J Geriatr Psychiatry Neurol 18 2005 250 255
14. S.M. Snapinn Noninferiority trials Curr Control Trials Cardiovasc Med 1 2000 19 21
15. L.A. Cupples, L.A. Farrer, A.D. Sadovnick, N. Relkin, P. Whitehouse, and R.C. Green Estimating risk curves for first-degree relatives of patients with Alzheimer's disease: the REVEAL Study Genet Med 6 2004 192 196
16. G. Piaggio, D.R. Elbourne, D.G. Altman, S.J. Pocock, and S.W. Evans Reporting of noninferiority and equivalence randomized trials: an extension of the consort statement JAMA 295 2006 1152 1160
17. B. Jones, P. Jarvis, J.A. Lewis, and A.F. Ebbutt Trials to assess equivalence: the importance of rigorous methods BMJ 313 1996 36 39
18. L.M. Collins, J.L. Schafer, and C.-M. Kam A comparison of inclusive and restrictive strategies in modern missing data procedures Psychol Methods 6 2001 330 351
19. W.W. Chung, C.A. Chen, L.A. Cupples, J.S. Roberts, S.C. Hiraki, A.K. Nair, and et al. A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease Alzheimer Dis Assoc Disord 23 2009 50 56
20. J.S. Roberts, C.A. Chen, W.R. Uhlmann, and R.C. Green Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease Genet Med 14 2012 742 748
21. K.D. Christensen, J.S. Roberts, W.R. Uhlmann, and R.C. Green Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk Genet Med 13 2011 409 414
22. J.S. Roberts, S.A. LaRusse, H. Katzen, P.J. Whitehouse, M. Barber, S.G. Post, and et al. Reasons for seeking genetic susceptibility testing among first-degree relatives of people with Alzheimer disease Alzheimer Dis Assoc Disord 17 2003 86 93
23. A. Edwards, J. Gray, A. Clarke, J. Dundon, G. Elwyn, C. Gaff, and et al. Interventions to improve risk communication in clinical genetics: systematic review Patient Educ Couns 71 2008 4 25
24. K.A. Calzone, S.A. Prindiville, O. Jourkiv, J. Jenkins, M. DeCarvalho, D.B. Wallerstedt, and et al. Randomized comparison of group versus individual genetic education and counseling for familial breast and/or ovarian cancer J Clin Oncol 23 2005 3455 3464
25. J. Jenkins, K. Calzone, E. Dimond, D. Liewehr, S. Steinberg, O. Jourkiv, and et al. Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling Genet Med 9 2007 487 495
26. M.J. Green, S.K. Peterson, M.W. Baker, G.R. Harper, L.C. Friedman, W.S. Rubinstein, and et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial JAMA 292 2004 442 452
27. T.A. Bensend, P.M. Veach, and K.B. Niendorf What's the harm? Genetic counselor perceptions of adverse effects of genetics service provision by non-genetics professionals J Genet Couns 2013 1 16
28. K.L. Brierley, D. Campfield, W. Ducaine, L. Dohany, T. Donenberg, K. Shannon, and et al. Errors in delivery of cancer genetics services: implications for practice Conn Med 74 2010 413 423
29. J.S. Roberts, M. Barber, T.M. Brown, L.A. Cupples, L.A. Farrer, S.A. LaRusse, and et al. Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial Genet Med 6 2004 197 203